Fund shareholders of GH RESEARCH PLC
ISIN IE000GID8VI0 · Ireland · LEI 875500HKJS7QQG6EWH62
- Fund shareholders
- 16
- Of which ETFs
- 7 9 other funds
- Value held
- 45.9M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 1,556,899 | 23.1M $ | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 530,287 | 7.9M $ | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 377,200 | 5.6M $ | 0.03 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 334,162 | 4.7M $ | 0.06 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 92,500 | 1.4M $ | 0.03 % | as of Feb 28, 2026 ↗ |
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 67,034 | 942.5K $ | 4.65 % | as of Mar 31, 2026 ↗ |
| iShares MSCI Ireland ETF iShares Trust | 38,522 | 572.1K $ | 0.81 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 35,645 | 529.3K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 24,077 | 338.5K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 21,175 | 434.7K $ | 1.16 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF SPDR INDEX SHARES FUNDS | 11,049 | 155.3K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 6,256 | 88K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Parametric International Equity Fund Eaton Vance Mutual Funds Trust | 4,100 | 84.2K $ | 0.04 % | as of Apr 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3,456 | 51.3K $ | 0.07 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,864 | 42.5K $ | 0.05 % | as of Feb 28, 2026 ↗ |
| First Trust IPOX Europe Equity Opportunities ETF First Trust Exchange-Traded Fund II | 118 | 1.7K $ | 0.04 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 4.65 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 1.16 % | as of Apr 30, 2026 ↗ |
| iShares MSCI Ireland ETF iShares Trust | 0.81 % | as of Feb 28, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.07 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.06 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 0.05 % | as of Feb 28, 2026 ↗ |
| Parametric International Equity Fund Eaton Vance Mutual Funds Trust | 0.04 % | as of Apr 30, 2026 ↗ |
| First Trust IPOX Europe Equity Opportunities ETF First Trust Exchange-Traded Fund II | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 0.03 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 16 | +4 | 3,105,344 | -0.5 % |
| 2026Q1 | 12 | +1 | 3,121,911 | +3.2 % |
| 2025Q4 | 11 | -2 | 3,025,296 | +8.0 % |
| 2025Q3 | 13 | +1 | 2,800,448 | +17.9 % |
| 2025Q2 | 12 | 0 | 2,375,557 | +50.4 % |
| 2025Q1 | 12 | -1 | 1,579,322 | -13.1 % |
| 2024Q4 | 13 | 0 | 1,817,312 | -2.4 % |
| 2024Q3 | 13 | 0 | 1,862,219 | +0.6 % |
| 2024Q2 | 13 | 0 | 1,851,484 | -9.5 % |
| 2024Q1 | 13 | 0 | 2,045,495 | -8.2 % |
| 2023Q4 | 13 | 2,229,292 |
Cite this page
Titelia. "Fund shareholders of GH RESEARCH PLC". https://titelia.com/en/stocks/gh-research-plc-IE000GID8VI0